Phase 2 data show significant reductions in nausea and vomiting that can cause patients to discontinue GLP-1s.
Researchers from across the country believe they have developed a breakthrough weight loss drug treatment: two new peptide compounds that could rival popular drugs like Ozempic and Wegovy, but without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback